<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="15843">Arachidonic acid</z:chebi> metabolites are under investigation as possible vasoactive agents involved in the pathogenesis of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> after <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="11" ids="26333">Prostaglandins</z:chebi>, as well as other vasoactive compounds, activate contractile proteins through utilization of extracellular bound <z:chebi fb="1" ids="39099">Ca+</z:chebi>+ to the intracytoplasmic free fraction </plain></SENT>
<SENT sid="2" pm="."><plain>Recently, calcium-<z:chebi fb="68" ids="48706">antagonists</z:chebi>, mainly Nimodipine, have been proposed for the prophylaxis and/or reversal of the ischemic damage caused by vasospasm </plain></SENT>
<SENT sid="3" pm="."><plain>Nimodipine failed to reduce vasospasm incidence in a series of 30 patients admitted with diagnosis of <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> from ruptured <z:hpo ids='HP_0004944'>intracranial aneurysm</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Nimodipine failed to reduce level of four <z:chebi fb="0" ids="32395">arachidonate</z:chebi> metabolites measured (<z:mp ids='MP_0002515'>prostaglandin D2</z:mp>, prostacyclin, <z:chebi fb="0" ids="28728">thromboxane B2</z:chebi> and <z:chebi fb="0" ids="16978">leukotriene C4</z:chebi>) in lumbar and cisternal CSF </plain></SENT>
<SENT sid="5" pm="."><plain>After <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> there is a significant increase of CSF levels of <z:chebi fb="0" ids="32395">arachidonate</z:chebi> metabolites; in perianeurysmic cisterns level of <z:mp ids='MP_0002515'>prostaglandin D2</z:mp>, <z:chebi fb="0" ids="28728">thromboxane B2</z:chebi> and <z:chebi fb="0" ids="16978">leukotriene C4</z:chebi> are significantly higher than lumbar CSF levels </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, cisternal CSF level of <z:mp ids='MP_0002515'>prostaglandin D2</z:mp> and <z:chebi fb="0" ids="16978">leukotriene C4</z:chebi> are significantly higher in patients with symptomatic vasospasm </plain></SENT>
<SENT sid="7" pm="."><plain>Nimodipine did not significantly modify <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CFS</z:e> level of <z:chebi fb="0" ids="32395">arachidonate</z:chebi> metabolites: this suggests that Nimodipine treatment, which definitely improves long-term results of patients for <z:hpo ids='HP_0004944'>intracranial aneurysms</z:hpo>, could exert its pharmacological action reducing <z:chebi fb="1" ids="39099">Ca+</z:chebi>+ intake from the extracellular compartment and preventing a direct toxic effect of calcium, without a direct action against the release of vasoactive compounds </plain></SENT>
</text></document>